Name: URGN Balance Sheet - Urogen Pharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

URGN - Urogen Pharma Ltd.

USD | NASDAQ | Healthcare

URGN Balance Sheet - Urogen Pharma Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Cash And Short Term Investments
Cash And Equivalents	110.7	172.0	95.0	55.4	44.4	52.9	49.7	101.3	37.0	21.4	18.0	3.9
Restricted Cash	1.4	1.1	0.8	0.8	1.2	1.2	0.5	0.3	-	-	-	-
Short Term Investments	49.3	110.7	56.2	-	-	-	-	-	36.0	-	-	-
Cash And Short Term Investments	160.1	282.7	151.2	55.4	44.4	52.9	49.7	101.3	73.0	21.4	18.0	3.9
Receivables
Accounts Receivable	33.1	20.3	15.4	12.7	11.7	7.0	-	-	-	0.1	-	-
Current Assets
Inventory	16.5	9.2	5.7	4.3	4.8	2.0	-	-	0.3	0.1	-	-
Prepaid Expenses	14.7	8.8
Non-Current Assets
Property, Plant & Equipment Gross	5.2	4.9	4.6	4.4	4.2	3.4	2.0	1.7	1.4	1.1	-	-
Accumulated Depreciation
Current Liabilities
Accounts Payable	12.1	10.9	6.5	5.5	5.8	3.3	4.7	4.3	2.8	-	-	-
Short Term Debt	-	-
Non-Current Liabilities
Long Term Debt	122.2	121.7	98.6	97.5	0.0	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	2.6
Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	-	-
Additional Paid In Capital	-	-
Supplementary Data
Total Debt	122.2	121.7	98.6	97.5	0.0	-	-	-	-	-	-	-
Net debt	(37.8)	(160.9)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q4 FY 15	Q4 FY 14
Cash And Short Term Investments
Cash And Equivalents	110.0	110.7	90.0	92.9	104.0	172.0	124.9	220.0	131.4	95.0	119.3	20.1	36.5	55.4	28.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Receivables
Accounts Receivable	55.4	33.1	19.7	19.6	19.6	20.3	22.8	17.4	14.2	15.4	12.8	15.5	12.5	12.7	9.4	11.6	9.5	11.7	7.8	9.5	6.3	7.0	2.8	0.4	-	-	-	-	-	-	0.1	0.2	0.0	-	-	-	-	-	-	-

Current Assets
Inventory	20.9	16.5	8.3	7.1	7.6	9.2	7.6	7.4	7.2	5.7	5.0	5.0	5.5	4.3	4.9	5.0	4.8	4.8	3.8	3.4	3.3	2.0	1.3	1.1	-	-	-	-	-	-	-	0.1	0.3	0.3	-	-	-	-	-	-
Prepaid Expenses	19.5	14.7	12.1	12.1	13.0	8.8	14.1	12.2	10.5	10.3	16.0	12.7	12.1	11.1	10.6	10.4	9.3	7.5
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	237.5	186.0	168.5	196.9	237.2	276.1	295.1	279.0	196.8	169.2	182.1	81.3	96.0	128.9	121.6	139.6

Current Liabilities
Accounts Payable	17.2	12.1	10.3	13.6	14.6	10.9	5.6	8.3	6.3	6.5	4.0	4.7	7.0	5.5	2.5	2.5	4.2	5.8	4.1	4.8	6.1	3.3	4.1	4.6	4.2	4.7	2.6	2.1	1.7	4.3	-	-	-	-	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.6	0.5	0.4	0.7	0.6	0.8	0.8	0.8	0.8	0.8	-	-	-	-	-	-
Accrued Expenses	9.8	13.5	11.1	11.6	7.0	10.6	9.0	6.8	5.0	10.8	8.2	6.7	4.9	8.3	6.6	6.4	5.1	6.9
Other Current Liabilities	5.5	5.2	5.0	4.9	4.7	7.9	4.1	3.6	3.2	3.9	3.6	3.6	3.2	3.3	3.0	3.0	4.0
Total Current Liabilities	50.6	46.4	42.2	47.5	42.0	45.9	32.8	34.2	26.3	31.2	25.8	26.8	25.2	23.9	19.0

Non-Current Liabilities
Long Term Debt	189.5	122.2	122.1	122.5	122.1	121.7	121.7	97.8	97.6	98.6	98.5	98.3	97.9	97.5	71.9	71.2	70.8	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	2.5	2.6	2.7	0.6	0.0	0.1	0.2	0.4	0.6	0.8	1.0	1.2	1.4	1.6	1.9	1.5
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	377.9	305.9	300.5	302.1	294.1	294.5	276.4	251.5	240.7	243.5	235.6	233.8	229.5	225.0	191.8	187.1

Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(983.3)	(959.7)	(933.4)	(900.0)	(850.1)	(806.2)	(768.7)	(745.0)	(711.6)	(679.3)	(653.3)	(631.5)	(607.3)	(577.1)	(548.2)	(522.4)	(495.7)
Accumulated Other Comprehensive Income	0.0	0.0	0.0	0.0	0.0	0.1	0.2	(0.0)	(0.0)	0.0	(0.1)	(0.2)	(0.0)	(0.1)	(0.2)	(0.1)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	(124.3)	(105.5)	(115.4)	(93.4)	(46.5)	(8.8)	25.5	30.3	(40.1)	(65.2)	(42.0)	(138.4)	(116.6)	(89.4)	(63.3)	(40.9)
Total Equity	(124.3)	(105.5)	(115.4)	(93.4)	(46.5)	(8.8)	25.5	30.3	(40.1)	(65.2)	(42.0)	(138.4)	(116.6)	(89.4)	(63.3)	(40.9)	(17.1)	8.4